Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12504935rdf:typepubmed:Citationlld:pubmed
pubmed-article:12504935lifeskim:mentionsumls-concept:C1858460lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C0002210lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C0032914lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C1141639lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C0021463lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C0032980lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C0050668lld:lifeskim
pubmed-article:12504935lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:12504935pubmed:issue1lld:pubmed
pubmed-article:12504935pubmed:dateCreated2002-12-30lld:pubmed
pubmed-article:12504935pubmed:abstractTextTo compare the serum levels of human chorionic gonadotrophin (hCG), alpha-fetoprotein, activin A, inhibin A and inhibin isoforms containing pro and alphaC in the second trimester serum of women who subsequently developed hypertensive disorders of pregnancy with those who remained normotensive throughout pregnancy.lld:pubmed
pubmed-article:12504935pubmed:languageenglld:pubmed
pubmed-article:12504935pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12504935pubmed:statusMEDLINElld:pubmed
pubmed-article:12504935pubmed:monthJanlld:pubmed
pubmed-article:12504935pubmed:issn1470-0328lld:pubmed
pubmed-article:12504935pubmed:authorpubmed-author:GroomeNigel...lld:pubmed
pubmed-article:12504935pubmed:authorpubmed-author:DavidsonEmma...lld:pubmed
pubmed-article:12504935pubmed:authorpubmed-author:RileySimon...lld:pubmed
pubmed-article:12504935pubmed:authorpubmed-author:RobertsStephe...lld:pubmed
pubmed-article:12504935pubmed:authorpubmed-author:ShearingCathe...lld:pubmed
pubmed-article:12504935pubmed:authorpubmed-author:MartinCameron...lld:pubmed
pubmed-article:12504935pubmed:issnTypePrintlld:pubmed
pubmed-article:12504935pubmed:volume110lld:pubmed
pubmed-article:12504935pubmed:ownerNLMlld:pubmed
pubmed-article:12504935pubmed:authorsCompleteYlld:pubmed
pubmed-article:12504935pubmed:pagination46-52lld:pubmed
pubmed-article:12504935pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:meshHeadingpubmed-meshheading:12504935...lld:pubmed
pubmed-article:12504935pubmed:year2003lld:pubmed
pubmed-article:12504935pubmed:articleTitleMaternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.lld:pubmed
pubmed-article:12504935pubmed:affiliationObstetrics and Gynaecology, Department of Reproductive and Developmental Sciences, University of Edinburgh, UK.lld:pubmed
pubmed-article:12504935pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12504935pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12504935lld:pubmed